The importance of the locally sustained pulmonary inflammation was underlined by the suppression of pulmonary NF-κB through administration of IL-10, which was followed by cytokine suppression and prevention of hepatic ischemia/reperfusion-induced lung injury [65]. This evidence concerns the gene NFKB1 and ischemia.